New Deep Learning Model SPLAIRE Improves Prediction of Splice Site Usage in Human Genes
Researchers developed SPLAIRE, a deep learning model trained on airway epithelial cell data from 100 donors, that outperforms existing models at predicting splice site usage in human pre-mRNA. Alternative splicing affects more than 95% of human protein-coding genes and is a major contributor to disease, making accurate computational prediction clinically important. The work also reveals persistent gaps in current state-of-the-art models, particularly for low-usage and tissue-specific splice sites.
SPLAIRE is a dilated convolutional neural network trained on one of the largest paired RNA and genotyping datasets used for this purpose to date, derived from cultured human airway epithelial cells across 100 donors. The study demonstrates that while existing deep learning splicing models report near-perfect overall performance metrics, significant prediction gaps remain — especially for splice sites with low usage rates and those that are tissue-specific. SPLAIRE not only outperforms current models on splice site identification and usage quantification within its training tissue but also generalizes to multiple tissues not included in training data. The authors provide what they describe as the most comprehensive evaluation of state-of-the-art splicing models published to date, assessing performance on genetic variant effect prediction alongside these identified shortcomings. The findings have implications for identifying pathogenic genetic variants that disrupt splicing, a mechanism underlying numerous human diseases.
What's missing
The study is a preprint posted to bioRxiv and has not yet undergone peer review, so findings should be interpreted with appropriate caution. The paper does not detail the demographic composition of the 100-donor training cohort, and generalizability to rare splice site variants and non-epithelial disease contexts remains an open question.
What different sources said
- bioRxivCenter
Improving splice site usage prediction with SPLAIRE
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.